Equity of access to innovative drugs and sustainability of pharmaceutical expenditure

Equity of access to innovative drugs and sustainability of pharmaceutical expenditure

Bibliographic Details
Main Author:	Mario Eandi
Format:	Article
Language:	English
Published:	SEEd Medical Publishers 2010-06-01
Series:	Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:	pharmacoeconomics health economics
Online Access:	https://journals.seedmedicalpublishers.com/index.php/FE/article/view/180

Similar Items

News from the Italian "Finanziaria 2008" and related pharmaceutical expenditure
by: Mario Eandi
Published: (2008-03-01)

New rules for the generic drugs market introduced by the "Decreto Abruzzi"
by: Mario Eandi
Published: (2009-03-01)

Theory and practice of the Health Technology Assessment in countries with a predominant public health service
by: Mario Eandi
Published: (2009-06-01)

A changing journal in a changing health care
by: Mario Eandi
Published: (2012-03-01)

Remuneration of community pharmaceutical services
by: Crealey, Grainne
Published: (1999)

Association between unemployment rates and prescription drug utilization in the United States, 2007–2010
by: Kozman Daniel, et al.
Published: (2012-11-01)

The cost-effectiveness of prevention: is an ounce of prevention worth a pound of cure?
by: Steven Simoens
Published: (2012-03-01)

E-cigarettes and Smoking Cessation: Economic Impact on Current Smokers with Chronic Obstructive Pulmonary Disease
by: Shah, Anal A
Published: (2017)

Rational and irrational factors in the dynamics of pharmaceutical expenditure and in the drug price negotiation
by: Mario Eandi
Published: (2006-09-01)

Expanded access to cancer treatments from conversion to neutropenia prophylaxis with biosimilar filgrastim-sndz
by: McBride, Ali, et al.
Published: (2017)

L’uso appropriato di antibiotici iniettivi a domicilio: criteri epidemiologici, clinici e farmacoeconomici
by: Mario Eandi, et al.
Published: (2005-03-01)

Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis
by: Anne Kangethe, et al.
Published: (2021-08-01)

Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
by: Milewska S, et al.
Published: (2021-09-01)

Value of drug or valuable drug: a point of view issue
by: Francesca Patarnello
Published: (2012-12-01)

The breakthrough of public pharmaceutical expenditure in 2005
by: Mario Eandi
Published: (2006-09-01)

Country and regional variations in purchase prices for essential cancer medications
by: Raphael E. Cuomo, et al.
Published: (2017-08-01)

PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING
by: M. V. Protsenko, et al.
Published: (2015-03-01)

Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
by: Kah Seng Lee, et al.
Published: (2021-12-01)

Systematic literature review to evaluate and characterize the health economics and outcomes research studies in India
by: Divya Mishra, et al.
Published: (2015-01-01)

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review
by: T. S. Romanenko, et al.
Published: (2015-09-01)

PHARMACOECONOMICS OF APPLICATION OF HEPATOPROTECTORS IN THERAPY OF DRUG-INDUCED LIVER INJURY AFTER CHEMOTHERAPY
by: D. D. Morikov, et al.
Published: (2017-04-01)

The pharmaceutical expenditure in Italy in 2009: toward regional federalism
by: Mario Eandi
Published: (2009-01-01)

Cancer Management in Saudi Arabia: Recommendations by the Saudi Oncology HeAlth Economics ExpeRt GrouP (SHARP)
by: Nora Alkhudair, et al.
Published: (2021-02-01)

Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
by: Junwen Zhou, et al.
Published: (2019-01-01)

Are Blood Cultures Useful in Patients with Skin and Soft Tissue Infections?
by: İlkay BOZKURT
Published: (2018-12-01)

Pharmacoeconomics as an instrument of clinical pharmacology for optimization of pharmacotherapy
by: Reshetko O.V., et al.
Published: (2015-09-01)

Research expenditures, regulation, and innovation in the ethical pharmaceutical industry
by: Jensen, Elizabeth Jane
Published: (2005)

Differences in selected medical care parameters in rheumatic disease ward patients of different ages of life
by: Piotr Pobrotyn, et al.
Published: (2016-06-01)

Measurement of Health Related Quality of Life in Malaria Patients in Indonesia using EQ-5D-5L
by: Dian Amalia Makatita, et al.
Published: (2019-07-01)

Impact of a Training Program in Pharmacoeconomics and Health Outcomes
by: Grizzle, Amy, et al.
Published: (2007)

PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION
by: V. A. Chibilyaev, et al.
Published: (2015-03-01)

Evaluation of Transparency to Improve Good Governance in Pharmaceutical Regulatory Sector of Iran
by: Yasaman Herandi, et al.
Published: (2020-09-01)

Decision-Making Associated with Drug Candidates in the Research and Development (R&D) Pipeline
by: Sarnowski, Jeff J.
Published: (2006)

Assessment and diffusion of medical innovations in France: an overview
by: Amélie Dubromel, et al.
Published: (2018-01-01)

PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE
by: E. I. Tarlovskaya, et al.
Published: (2015-09-01)

Regional control of pharmaceutical expenditure in the DL May 31, 2010 No 78
by: Mario Eandi
Published: (2010-03-01)

Evaluación de la calidad de las webs de centros de farmacoeconomía y economía de la salud en Internet mediante un cuestionario validado Evaluation of the quality of the websites of pharmacoeconomics and health economics centers through a validated questionnaire
by: Ana Domínguez-Castro, et al.
Published: (2004-08-01)

A Review of the Pharmacist as Vaccinator
by: Willis M. Richardson, et al.
Published: (2019-07-01)

Outcomes research and drug development
by: Sandeep Duttagupta
Published: (2010-01-01)

How much to invest in glycemic control of a patient with diabetes mellitus type 2? A constant dilemma for the Brazilian Public Health System (SUS)
by: Ana Carolina de Oliveira Gonçalves, et al.